Two Sigma Investments
JUNO

Two Sigma Investments’s Juno Therapeutics, Inc. JUNO Stock Holding History

Two Sigma Investments’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-149,969
Closed -$6.86M – 3783
2017
Q4 		$6.86M Sell
149,969
-106,493
-42% -$5.31M 0.02% 763
2017
Q3 		$11.5M Buy
+256,462
New +$8.74M 0.04% 469

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Investments's JUNO Position: Q1 2018 in Review

Two Sigma Investments sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 149,969 shares — an estimated $6.86M sold.

Two Sigma Investments first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $11.5M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Two Sigma Investments reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Investments sold 149,969 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.86M.
  • Two Sigma Investments first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Two Sigma Investments's Juno Therapeutics, Inc. position peaked at $11.5M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.